1 | uc san francisco and | | | | | | | 4 | 0.20% |
2 | in bioengineering from uc | | | | | | | 4 | 0.20% |
3 | amd dme dr and | | | | | | | 3 | 0.15% |
4 | senior vice president of | | | | | | | 3 | 0.15% |
5 | vice president of technical | | | | | | | 3 | 0.15% |
6 | president of technical operations | | | | | | | 3 | 0.15% |
7 | chief executive officer of | | | | | | | 3 | 0.15% |
8 | previously served as the | | | | | | | 3 | 0.15% |
9 | dme dr and rvo | | | | | | | 3 | 0.15% |
10 | wet amd dme dr | | | | | | | 3 | 0.15% |
11 | law school and a | | | | | | | 2 | 0.10% |
12 | been actively involved in | | | | | | | 2 | 0.10% |
13 | has been actively involved | | | | | | | 2 | 0.10% |
14 | phd has been actively | | | | | | | 2 | 0.10% |
15 | jackson phd has been | | | | | | | 2 | 0.10% |
16 | and a ba from | | | | | | | 2 | 0.10% |
17 | school and a ba | | | | | | | 2 | 0.10% |
18 | stanford law school and | | | | | | | 2 | 0.10% |
19 | entrepreneurship for over 20 | | | | | | | 2 | 0.10% |
20 | from stanford law school | | | | | | | 2 | 0.10% |
21 | jd from stanford law | | | | | | | 2 | 0.10% |
22 | a jd from stanford | | | | | | | 2 | 0.10% |
23 | obtained a jd from | | | | | | | 2 | 0.10% |
24 | ostrach obtained a jd | | | | | | | 2 | 0.10% |
25 | mr ostrach obtained a | | | | | | | 2 | 0.10% |
26 | at several private biotechnology | | | | | | | 2 | 0.10% |
27 | actively involved in biotechnology | | | | | | | 2 | 0.10% |
28 | business officer and general | | | | | | | 2 | 0.10% |
29 | chief financial officer chief | | | | | | | 2 | 0.10% |
30 | of valitors founding team | | | | | | | 2 | 0.10% |
31 | which now forms the | | | | | | | 2 | 0.10% |
32 | novel proteinbiopolymer conjugation technology | | | | | | | 2 | 0.10% |
33 | the novel proteinbiopolymer conjugation | | | | | | | 2 | 0.10% |
34 | inlicense the novel proteinbiopolymer | | | | | | | 2 | 0.10% |
35 | to inlicense the novel | | | | | | | 2 | 0.10% |
36 | founding team and helped | | | | | | | 2 | 0.10% |
37 | valitors founding team and | | | | | | | 2 | 0.10% |
38 | part of valitors founding | | | | | | | 2 | 0.10% |
39 | over 20 years as | | | | | | | 2 | 0.10% |
40 | was part of valitors | | | | | | | 2 | 0.10% |